Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor, induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines

Molecular pharmacology (2007) - Comments
pubmed: 17456787 doi: 10.1124/mol.107.034827 issn: 0026-895x issn: 1521-0111

Yi-He Ling, Tianhong Li, Ziqiang Yuan, Missak Haigentz, Thomas K. Weber, Roman Perez-Soler